Latest Eastern Cooperative Oncology Group Stories
FRANKLIN, Tenn., March 16 /PRNewswire/ -- MedSolutions (www.medsolutions.com), a leading provider of medical cost management services, today announced the launch of its oncology management program, which uses evidence-based guidelines to ensure appropriate use of diagnostic imaging, radiation therapy and drugs for cancer patients.
THE WOODLANDS, Texas, March 2 /PRNewswire/ -- In only its second year as an Affiliate Member of Radiation Therapy Oncology Group (RTOG), US Oncology, Inc.
Regimen with new drug triapine provides both significant reduction in cancer disease and cancer control.
SCOTTSDALE, Ariz., Feb.
RALEIGH, N.C., Jan.
Growing Use of Oral Chemotherapeutics Brings Clinical Benefits, Raises Questions in Prescribing, Adherence, Accessibility and Long Term Follow-Up Care According to Panel WASHINGTON, Jan. 21 /PRNewswire-USNewswire/ -- US Oncology, Inc.
NCCN updates the NCCN Guidelines for Non-Small Cell Lung Cancer to include guidance on maintenance therapy, several new therapeutic recommendations for specific patients with Non-Small Cell Lung Cancer, and a revised staging system. FORT WASHINGTON, Pa., Dec.
DALLAS, Nov. 24 /PRNewswire-USNewswire/ -- The Baylor Charles A. Sammons Cancer Center has become a full member of one of the largest cancer clinical trials cooperative groups in the United States.
NCCN program on Discovery Health Channel profiles patients undergoing treatment for metastatic breast cancer and their physicians' use of the NCCN Clinical Practice Guidelines in Oncology(TM) for Breast Cancer to determine an individualized treatment regimen.
NCCN recently received a research grant from Allos Therapeutics, Inc. to evaluate the role of pralatrexate in the treatment of select hematologic malignancies and solid tumors.
- Large; stout; burly.